Cholinesterase inhibition in Parkinson's disease

被引:112
作者
Hutchinson, M
Fazzini, E
机构
关键词
D O I
10.1136/jnnp.61.3.324-a
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:324 / 325
页数:2
相关论文
共 6 条
[1]   A DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY OF TACRINE FOR ALZHEIMERS-DISEASE [J].
DAVIS, KL ;
THAL, LJ ;
GAMZU, ER ;
DAVIS, CS ;
WOOLSON, RF ;
GRACON, SI ;
DRACHMAN, DA ;
SCHNEIDER, LS ;
WHITEHOUSE, PJ ;
HOOVER, TM ;
MORRIS, JC ;
KAWAS, CH ;
KNOPMAN, DS ;
EARL, NL ;
KUMAR, V ;
DOODY, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (18) :1253-1259
[2]   A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE [J].
KNAPP, MJ ;
KNOPMAN, DS ;
SOLOMON, PR ;
PENDLEBURY, WW ;
DAVIS, CS ;
GRACON, SI ;
APTER, JT ;
LAZARUS, CN ;
BAKER, KE ;
BARNETT, M ;
BAUMEL, B ;
EISNER, LS ;
CASTELLS, B ;
BOLOURI, R ;
BENNETT, D ;
FORCHETTI, C ;
LEVIN, A ;
BLASS, JP ;
NOLAN, KA ;
GAINES, ER ;
RELKIN, N ;
BORISON, RL ;
DIAMOND, B ;
CELESIA, GG ;
ROSS, AP ;
DEXTER, J ;
DOODY, R ;
LIPSCOMB, L ;
KREITER, K ;
DUBOFF, EA ;
BLOCK, P ;
MARSHALL, D ;
WESTERGAARD, N ;
EARL, NL ;
WYNE, SV ;
HINMANSMITH, E ;
FARLOW, M ;
HENDRIE, HC ;
CARESS, JA ;
FARMER, M ;
HARPER, JE ;
FERGUSON, J ;
FOSTER, NL ;
BARBAS, NR ;
BLUEMLEIN, LA ;
GELB, DJ ;
BERENT, S ;
GIORDANI, B ;
GREENWALD, M ;
BERGMAN, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (13) :985-991
[3]   LEWY BODIES AND RESPONSE TO TACRINE IN ALZHEIMERS-DISEASE [J].
LEVY, R ;
EAGGER, S ;
GRIFFITHS, M ;
PERRY, E ;
HONAVAR, M ;
DEAN, A ;
LANTOS, P .
LANCET, 1994, 343 (8890) :176-176
[4]   PARKINSONS-DISEASE - NEURON LOSS IN THE NUCLEUS BASALIS WITHOUT CONCOMITANT ALZHEIMERS-DISEASE [J].
NAKANO, I ;
HIRANO, A .
ANNALS OF NEUROLOGY, 1984, 15 (05) :415-418
[5]   EXACERBATION OF PARKINSONISM BY TACRINE [J].
OTT, BR ;
LANNON, MC .
CLINICAL NEUROPHARMACOLOGY, 1992, 15 (04) :322-325
[6]   TACRINE FOR SENILE DEMENTIA OF ALZHEIMERS OR LEWY BODY TYPE [J].
WILCOCK, GK ;
SCOTT, MI .
LANCET, 1994, 344 (8921) :544-544